AzTrials
AzTrials

ADHDNCT06774378

Efficacy of an Occupational Intervention for Improving Quality of Work Life in Adults Living With ADHD

A study testing Minds@Work-ADHD-Quality of Life and Minimal contact in people with ADHD, run by Université du Québec a Montréal at 1 site in Canada.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

An adaptation of the Minds@Work intervention to improve quality of life at work for adults living with attention deficit disorder with/without hyperactivity (ADHD), following a group format. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
ADHD
What is being tested?
Minds@Work-ADHD-Quality of Life and Minimal contact
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteCanada
Study dates
28 Aug 2024to May 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years
  • French language proficiency
  • Score ≤ 4 on Part A of the Adult ADHD Self-Report Scale (ASRS-v1.1)
  • Currently employed
  • Express desire to improve Quality of Work Life (QoWL)

Who cannot join

  • Currently receiving psychosocial services (e.g., psychotherapy, occupational therapy) specifically targeting QoWL improvement

Trial locations and contacts

1 site in 1 country.

Canada1 site

  • Université du Québec à Montréal

    Montreal, Quebec, H2X 3R9

Other trials in Canada

About this study

Official title: Efficacy of an Occupational Intervention for Quality of Work Life in ADHD: A Randomized Controlled Trial Protocol

An adaptation of the Minds@Work intervention to improve quality of life at work for adults living with attention deficit disorder with/without hyperactivity (ADHD), following a group format.

Read the detailed description

In this study, the research team has developed a psychosocial group intervention specifically aimed at improving quality of life at work for ADHD workers. Work-related themes cover motivation, accommodations, problem solving, cognitive functions (i.e. attention and memory), hyperactivity and impulsivity, interpersonal interactions, and medication management.

The general objective of this project is to evaluate the effectiveness of this new psychosocial intervention aimed at improving the quality of life at work of workers living with ADHD, using a randomized controlled trial design.

More specifically, the project will aim to:

Objective #1: Evaluate the effectiveness of the intervention on the quality of life at work of workers living with ADHD (primary outcome).

Objective #2: Evaluate the effectiveness of the intervention on secondary variables, namely the satisfaction of psychological needs, job satisfaction, well-being at work, self-esteem as a worker, occupational self-efficacy, cognitive functioning, self-compassion and the quality of the relationship with members of the workplace (secondary outcomes).

  • Hypothesis #1: There will be a statistically significant improvement in the quality of life at work between the pre- and post-intervention measurements in participants receiving the experimental condition.
  • Hypothesis #2: There will be a statistically significant condition*time interaction indicating that the improvement in quality of work life among participants receiving the experimental condition between the pre- and post-intervention measurement times will be greater than that of the control condition.
  • Hypotheses #3 to 10: There will be a statistically significant improvement in the secondary outcomes mentioned above between the pre- and post-intervention measurements among participants receiving the experimental condition.
  • Hypothesis #11: For participants receiving the experimental condition, there will be no statistically significant difference in quality of work life between the follow-up times, indicating that the gains acquired during the intervention will be maintained at 3, 6, 9, and 12 months.

Our research team collaborates with the PANDA Les Deux-Rives association, which is a non-profit organization specializing in ADHD. The psychosocial intervention was co-designed, which allows the involvement of field stakeholders in all stages of the research. This involvement promotes the creation of a final research output that will meet the needs of the target population and that will be easily implemented in the organizational structures already in place.

Conditions
ADHD
Being tested
Minds@Work-ADHD-Quality of Life, Minimal contact
Keywords
ADHD, RCT, intervention, quality of life, work, mental health, workplace, quality of work life
Medical subject headings
Attention Deficit Disorder with Hyperactivity, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Minds@Work-ADHD-Quality of LifeBehavioural

    Minds@Work-ADHD-Quality of Life

  • Minimal contactBehavioural

    Weekly 15-minute scripted phone calls made individually by a member of the research team to offer minimal support, without any active intervention.

Study groups in NCT06774378
Study groupRoleWhat they receive
InterventionExperimentalMinds@Work-ADHD-Quality of Life
Receives: Behavioral: Minds@Work-ADHD-Quality of Life
ControlPlacebo comparatorMinimal contact comparison approach
Receives: Behavioral: Minimal contact

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Quality of Work Life as Measured by Quality of Work Life Questionnaire (QWLQ) Total Score

    The QWLQ will be used to assess multiple dimensions of work-related quality of life, including work tasks, workplace environment and conditions, self-esteem as a worker, sense of belonging to a workgroup, and relationships with coworkers/supervisors. The questionnaire consists of 40 items rated on a 4-point Likert scale (1 = completely disagree to 5 = completely agree). Total scores range 40-200, with higher scores indicating greater perceived quality of work life.

    Measured: Assessed at baseline (pre-intervention), immediately after the intervention, and at 3, 6, 9, and 12 months post-intervention

Secondary outcomes (8)

  1. Change in Psychological Need States at Work Scale (PNSW-S) Score

    The PNSW-S assesses satisfaction, frustration, and unfulfillment of basic psychological needs (autonomy, competence, relatedness) in the workplace. The 37-item questionnaire uses a Likert scale, with higher scores (Min = 37, Max = 259) indicating greater psychological need satisfaction. The scale measures intrinsic motivation based on self-determination theory.

    Measured: Assessed at baseline (pre-intervention), immediately after the intervention, and at 3, 6, 9, and 12 months post-intervention

  2. Change in Minnesota Satisfaction Questionnaire-Short Form (MSQ-SF) Scores

    The MSQ-SF is a 20-item measure assessing three domains: Intrinsic Job Satisfaction (task-related attitudes), Extrinsic Job Satisfaction (working conditions/environment), and General Satisfaction. Items are rated on a Likert scale, with higher scores indicating greater job satisfaction in each domain (Min = 20, Max = 100) .

    Measured: Assessed at baseline (pre-intervention), immediately after the intervention, and at 3, 6, 9, and 12 months post-intervention

  3. Change in Index of Psychological Well-Being at Work (IPWBW) Score

    The IPWBW is a 25-item measure assessing five dimensions of well-being at work: Interpersonal Fit, Thriving, Feeling of Competency, Desire for Involvement, and Perceived Recognition at Work. Items are rated on a Likert scale, with higher scores indicating greater psychological well-being at work (Min = 0, Max = 100) .

    Measured: Assessed at baseline (pre-intervention), immediately after the intervention, and at 3, 6, 9, and 12 months post-intervention

  4. Change in Individual Self-Esteem as a Worker (ISEW) Scale Score

    The ISEW is a 10-item scale measuring individual and social dimensions of worker self-esteem. Items are rated on a Likert scale, with higher scores indicating greater self-esteem as a worker (Min = 10, Max = 40).

    Measured: Assessed at baseline (pre-intervention), immediately after the intervention, and at 3, 6, 9, and 12 months post-intervention

  5. Change in Occupational Self-Efficacy Scale-Short Version (OSES) Score

    The OSES is a 6-item measure assessing workers' sense of self-efficacy based on Bandura's self-efficacy theory. Items are rated on a Likert scale, with higher scores indicating greater occupational self-efficacy (Min = 6, Max = 36).

    Measured: Assessed at baseline (pre-intervention), immediately after the intervention, and at 3, 6, 9, and 12 months post-intervention

  6. Change in Self-Compassion Scale-Short Form (SCS-S) Score

    The SCS-S is a 12-item measure assessing self-kindness, self-judgment, and feelings of loneliness. Items are rated on a Likert scale, with higher scores indicating greater self-compassion in work settings (Min = 12, Max = 60).

    Measured: Assessed at baseline (pre-intervention), immediately after the intervention, and at 3, 6, 9, and 12 months post-intervention

  7. Change in Cognitive Function at Work Questionnaire (CFWQ) Score

    The CFWQ is a 29-item measure assessing subjective cognitive difficulties in six domains: Memory, Language, Executive Function, Speed of Processing, Cognitive Control, and Name Memory. Items are rated on a Likert scale, with higher scores indicating better cognitive functioning at work (Min = 0, Max = 58).

    Measured: Assessed at baseline (pre-intervention), immediately after the intervention, and at 3, 6, 9, and 12 months post-intervention

  8. Change in Team-Member Exchange (TMX) Survey Score

    The TMX is a 9-item survey measuring the quality of professional relationships between adults with ADHD and workplace stakeholders. Items are rated on a Likert scale, with higher scores indicating better quality of work relationships (Min = 9, Max = 63).

    Measured: Assessed at baseline (pre-intervention), immediately after the intervention, and at 3, 6, 9, and 12 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jan 2025
  2. Study start28 Aug 2024
  3. Primary completionMay 2025 (estimated)
  4. Study completionMay 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06774378
Sponsor's protocol ID
2023-0SYA-312580
Status last verified
May 2025
First submitted
26 Nov 2024
Last updated
16 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: For this project, IPD sharing is not included in the ethical approval provided by our Institutional Review Board (IRB).

Publications

  • Sauve G, Buck G, Lepage M, Corbiere M. Minds@Work: A New Manualized Intervention to Improve Job Tenure in Psychosis Based on Scoping Review and Logic Model. J Occup Rehabil. 2022 Sep;32(3):515-528. doi: 10.1007/s10926-021-09995-2. Epub 2021 Jul 30.

    PubMed 34331191

  • Voyer C, Corbiere M, Villotti P, Stamate AN, Sauve G. Efficacy of an occupational intervention for quality of work life in ADHD: A randomized controlled trial protocol. Contemp Clin Trials. 2025 Aug;155:107997. doi: 10.1016/j.cct.2025.107997. Epub 2025 Jun 30.

    PubMed 40602661

Questions about this trial

What is this clinical trial studying?

A study testing Minds@Work-ADHD-Quality of Life and Minimal contact in people with ADHD, run by Université du Québec a Montréal at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 16 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Quality of Work Life as Measured by Quality of Work Life Questionnaire (QWLQ) Total Score (time frame: Assessed at baseline (pre-intervention), immediately after the intervention, and at 3, 6, 9, and 12 months post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06774378, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2025.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in